Liminatus Pharma Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 05/15/2026 | 677.52 K | $116.47 K | 855.19% | 2.85% |
| 05/13/2026 | 350.00 K | $60.00 K | 100.00% | 1.47% | |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 117.78 K | $20.25 K | 81.06% | 0.50% |
| JANE STREET GROUP, LLC | 05/12/2026 | 71.32 K | $12.26 K | 100.00% | 0.30% |
| UBS GROUP AG | 05/05/2026 | 54.58 K | $9.39 K | 181.40% | 0.23% |
| 05/15/2026 | 50.44 K | $8.68 K | 100.00% | 0.21% | |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 05/14/2026 | 34.71 K | $5.97 K | 100.00% | 0.15% |
| VIRTU FINANCIAL LLC | 05/14/2026 | 27.47 K | $5.00 K | 100.00% | 0.12% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 22.98 K | $3.95 K | 100.00% | 0.10% |
| TWO SIGMA SECURITIES, LLC | 05/15/2026 | 22.04 K | $3.79 K | 85.59% | 0.09% |
| STATE STREET CORP | 05/15/2026 | 19.00 K | $3.27 K | 0.00% | 0.08% |
| BLACKROCK, INC. | 05/13/2026 | 13.25 K | $2.28 K | -0.01% | 0.06% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 7.57 K | $1.30 K | -15.01% | 0.03% |
| CITIGROUP INC | 05/11/2026 | 6.77 K | $1.16 K | 676,800.00% | 0.03% |
| FARTHER FINANCE ADVISORS, LLC | 04/07/2026 | 14 | $2 | -54.84% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Liminatus Pharma Inc. institutional Ownership - FAQ's
During the previous two years, 16 institutional investors and hedge funds held shares of Liminatus Pharma Inc.. The most heavily invested institutionals were:
CITADEL ADVISORS LLC: 677,518
GEODE CAPITAL MANAGEMENT, LLC: 117,783
JANE STREET GROUP, LLC: 71,318
UBS Group AG: 54,578
Vanguard Personalized Indexing Management, LLC: 34,706
Virtu Financial LLC: 27,468
6.21% of Liminatus Pharma Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.15 M shares in the last 24 months. This purchase volume represents approximately $264.14 K in transactions.